Cell line · CVCL_0033
SK-BR-3
Cancer cell line, Homo sapiens. Breast adenocarcinoma. 217 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. SK-BR-3. Cell lines, record CVCL_0033. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0033
On this page
Cell line
As Cellosaurus gives it.
- Name
- SK-BR-3
- Accession
- CVCL_0033
- RRID
- RRID:CVCL_0033
- Synonyms
- SK-Br-3, Sk-Br-3, SK BR 03, SKBR-3, SKBr-3, SK-BR3, SKBr3, SkBr3, SKBR3
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 43Y
- Category
- Cancer cell line
- Diseases
- Breast adenocarcinoma (NCIt C5214)
- Derived from
- Pleural effusion (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers217
3 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy. | Nat Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Impact of Trastuzumab and Pertuzumab on HER2 Localization and the Estrogen Receptor Cistrome in ER+/HER2+ Breast Cancer. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The role of autoproteolysis and mitoribosomal proteins in the regulation of the mitochondrial LACTB tumor suppressor. | EMBO Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of HOX/PBX Dimers as a Potential Therapeutic Strategy in Breast Cancer Subtypes Including Triple Negative Breast Cancer. | Curr Issues Mol Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Bioinformatic Identification and Experimental Validation of a Prognostic Transcriptional Signature Derived from Asparagine Metabolism-Related Genes in Breast Cancer. | Biology (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CRB-701: A Second-generation Nectin-4-Targeted Antibody-Drug Conjugate with Optimized Stability and Pharmacokinetics for the Treatment of Solid Tumors. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| AI-Assisted Tumor Boundary Delineation via Targeted Ultrasmall Iron Oxide Nanoprobe for High-Contrast HER2-Positive Tumor Imaging. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HSPA8 globally modulates transcriptome profile and PI3K/AKT signaling pathway to facilitate malignant progression phenotypes of triple-negative breast cancer. | Sci Prog | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Controllable Cascade Aggregation Ion Programmed Nanomachines and Simple Isolation Enable Tumor-Derived Small Extracellular Vesicles Detection for Enhanced Breast Cancer Assessment. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 217
See all 217 papersRelatives30
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE SK-BR-3-CopGFP | CVCL_F6BA | Cell lines | |
| Derived from it | EDITGENE SK-BR-3-FLUC | CVCL_F5TN | Cell lines | |
| Derived from it | EDITGENE SKBR3-Cas9 | CVCL_F5Q1 | Cell lines | |
| Derived from it | LINTERNA SK-BR-3 | CVCL_YJ92 | Cell lines | |
| Derived from it | LR-SKBR3 | CVCL_A2GI | Cell lines | |
| Derived from it | SK-BR-3 shPARG | CVCL_RA92 | Cell lines | |
| Derived from it | SK-BR-3 shWDR12-4 | CVCL_YJ28 | Cell lines | |
| Derived from it | SK-BR-3-EGFP | CVCL_C8WI | Cell lines | |
| Derived from it | SK-BR-3-LR | CVCL_4V52 | Cell lines | |
| Derived from it | SK-BR-3-Luc [JCRB] | CVCL_4Y11 | Cell lines |
1 to 10 of 30
See all 30 relativesCell banks18
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-30 | ATCC | |
| AddexBio | C0006007/65 | Cellosaurus | |
| BCRJ | 0226 | BCRJ | |
| CCTCC | GDC0286 | Cellosaurus | |
| CLS | 300333 | CLS | |
| CancerTools | 161911 | CancerTools | |
| DSMZ | ACC-736 | DSMZ | |
| EDITGENE | EDC00219 | EDITGENE | |
| Hysigen | TCH-C328 | Hysigen | |
| IBRC | C10147 | Cellosaurus |
1 to 10 of 18
See all 18 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0033
GET https://conductscience.org/api/cell-lines/v1/CVCL_0033/papers?page=2